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Abstract 
Background: Rapid identification of novel targets and advancement of a vascular targeting strategy requires a 
comprehensive assessment of AVM endothelial membrane protein changes in response to irradiation. The aim of this 
study is to provide additional potential target protein molecules for evaluation in animal trials to promote intravascu-
lar thrombosis in AVM vessels post radiosurgery.
Methods: We employed in vivo biotinylation methodology that we developed, to label membrane proteins in the rat 
model of AVM post radiosurgery. Mass spectrometry expression  (MSE) analysis was used to identify and quantify sur-
face protein expression between irradiated and non irradiated rats, which mimics a radiosurgical treatment approach.
Results: Our proteomics data revealed differentially expressed membrane proteins between irradiated and non 
irradiated rats, e.g. profilin-1, ESM-1, ion channel proteins, annexin A2 and lumican.
Conclusion: This work provides additional potential target protein molecules for evaluation in animal trials to pro-
mote intravascular thrombosis in AVM vessels post radiosurgery.
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Introduction
Brain AVMs are the major cause of hemorrhagic stroke 
in adults and young children with each haemorrhage 
caring a 50% risk of death or morbidity [1]. Radiosur-
gery is the treatment recommended for lesions < 3  cm 
in diameter. Radiosurgery is relatively safe when treat-
ing small lesions < 2.6  cm in diameter, without the risk 
of high radiation exposure to the surrounding tissues. 
Vascular occlusion after radiosurgery may take 2–3 years 
to complete therefore the risk of haemorrhage is not 
eliminated until complete obliteration is achieved [2, 3]. 
Promoting rapid thrombosis after radiosurgery by target-
ing endothelial surface discriminating proteins has the 
potential to overcome the downside of radiosurgery. The 
processes of AVM vessel occlusion after radiosurgery are 
not understood completely, it is suggested to be involved 
a combination of cellular proliferation and intravascular 
thrombosis [4, 5]. We have developed an animal model 
of AVM and demonstrated the ability of stimulating 
thrombosis in AVM vessels after radiosurgery by non-
ligand vascular targeting approach, however only small 
vessels showed a sign of thrombosis, and the non-ligand 
injection is not safe for use in humans [6–8]. Therefore 
a ligand based approach has the potential to overcome 
Open Access
Clinical Proteomics
*Correspondence:  margaret@chem.ucla.edu 
2 Department of Biological Chemistry, David Geffen School of Medicine, 
University of California Los Angeles (UCLA), 611 Charles E. Young Drive 
East, Los Angeles, CA 90095, USA
Full list of author information is available at the end of the article
Page 2 of 8Simonian et al. Clin Proteom           (2018) 15:43 
these obstacles. To achieve this goal, we have developed 
in vitro and in vivo biotinylation perfusion methodology 
to label endothelial cell surface proteins in murine bEnd. 
3 cell cultures and the animal model of AVM [9, 10] and 
we have shown the feasibility of employing proteomics 
methods on the arteriovenous fistula (AVF) tissues har-
vested from the animal model [9, 10]. Here, we employ 
our in vivo methodology to label, then identify and quan-
tify the differentially expressed membrane proteins in 
the irradiated and non irradiated animals using a label-
free quantitative mass spectrometry of expression  (MSE) 
technique.
Based on our previous proteomics study of the murine 
endothelial cell cultures (bEnd.3), the most extensive 
membrane protein changes in response to irradiation 
were observed at 24  h post irradiation [11]. Therefore 
in this study, the membrane protein changes in the rat 
model of AVM were studied at 24  h post irradiation. 
Up-regulated membrane proteins in the irradiated rats 
compare to the controls will be investigated as poten-
tial targets for the AVM ligand-directed molecular ther-
apy to stimulate rapid thrombosis in AVM vessels post 
radiosurgery.
Materials and methods
Rats
An arteriovenous fistula (AVF) was created in six 
Sprague-Dawley male rats weighing from 360 to 411  g, 
according to Yassari et  al. protocol [6]. Rats were 
returned to the animal care facility after the operation 
and monitored daily for the first week then weekly for 
another 5 weeks, allowing the fistula to reach maturity.
Radiosurgery of the rats
After 6 weeks of creating the fistulas, three rats were irra-
diated using the Leksell Gamma knife (Elekta, Stockholm, 
Sweden) at Macquarie University Hospital by delivering 
15 Gy to the AVF tissues directly, minimizing the dose to 
the trachea to less than 10 Gy. The remaining three rats 
were used as controls.
In vivo biotinylation perfusion
After 24  h of irradiation, all six rats were narcotized, 
prepared and perfused per Simonian et  al. [9] protocol, 
with a slight modification. A Gilson Minipuls 3 perfu-
sion pump attached to a tube and needle was used to 
perfuse the rats with 1  mL of saline (NaCl) with a flow 
rate of 50 mL/min to wash away the blood, immediately 
followed with 100  mL of freshly prepared biotinylation 
solusion [1.5  mg/mL of Sulfo-NHS-LC-Biotin in pre 
warmed PBS at 37 °C + 10% Dextran 40] by pressing the 
syringe plug with a flow rate of 25 mL/min while moni-
toring the pressure and keeping it constant at ~ 100 mm 
Hg. After 5  min of perfusing the biotinylation solution, 
the rats were injected with 100 mL of (50 mM Tris–Hcl 
in PBS + 10% Dextran 40) with a flow rate of 30 mL/min 
to wash out excessive biotinylation reagent, then were 
perfused with 200 mL saline at 30 mL/min to wash away 
Dextran. The fistula tissues were then excised and the 
surrounding fat and muscle tissue were removed. The 
vascular tissues were placed in a 1  mL Eppendorf tube 
and transferred to a − 80 °C freezer immediately.
Membrane protein extraction
The harvested vascular tissues were homogenized using 
tissue grinder with pestle (Wheaton) in 1  mL of lysis 
buffer (20  mM HEPES, 150  mM NaCl, 10  mM NaF, 
1 mM Na-EDTA, 1 mM Na-EGTA, pH 7.5, pH adjusted 
with NaOH, 0.1% Triton-X v/v) + protease inhibitor (4 µL 
per mL of HEPES buffer, Sigma P-2714). Samples were 
probe sonicated for 15 s, three times using the Branson 
Sonifier 450 (John Morris Scientific) and centrifuged in 
a pre-cooled rotor at 1500×g for 15 min at (4 °C). Super-
natants were collected and pellets were re-lysed with 
0.5  mL of HEPES buffer (same as above steps). Super-
natants were collected and pooled with previous super-
natants, the final volume of supernatants were ~ 1.5 mL. 
Sodium Bicarbonate solution (0.1 M, pH 11) was added 
to pooled supernatants (up to 5  mL) and incubated for 
1 h at 4  °C on rocking platform. After incubation, sam-
ples were centrifuged at 100,000×g for 45  min at 4  °C. 
Pellets were washed with 0.5  mL of 100% cold acetone 
twice and left to dry. Pellets were then dissolved with 200 
µL of 100 mM Amonium Bicarbonate containing 10 mM 
DTT (freshly prepared) in water bath sonication (FS30H, 
Fisher Scientific) for 20 min and then incubated for 1 h 
at 37  °C to reduce the samples. To alkalize the samples, 
5µL of 1 M idoacetamide stock was added to make final 
concentration to 20  mM idoacetamide and incubate in 
dark at room temperature for 30  min. Samples volume 
were then brought up to 5 mL with 100 mM Amonium 
Bicarbonate and centrifuged at 100,000×g for 1 h at 4 °C. 
Pellets were dissolved with 400 µL of 100 mM Amonium 
Bicarbonate in water bath sonication then 600 µL of 
methanol was added.
Capture of biotinylated proteins
Biotinylated proteins were captured on streptavidin 
Sepharose (GE health care, USA). Five hundred microli-
tres of streptavidin Sepharose were washed three times 
with buffer A containing (1% w/v NP40, 0.5% w/v SDS 
in PBS), then three times with 500 µL PBS. Samples 
then were incubated with washed streptavidin Sepha-
rose for 2  h at room temperature with gentle rotation. 
Streptavidin Sepharose was pelleted by centrifugation at 
1600×g for 5 min. Unbound proteins were eliminated by 
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washing three times with 1 mL of 1% Triton-x (v/v), once 
with 400  µL of 1% SDS (w/v) and five times with 1  mL 
of digestion buffer 0.25 mM ammonium bicarbonate. The 
use of high salt concentration and NP40 detergent in the 
washing buffers minimises the non-specific interactions 
of biotin and streptavidin.
Tryptic digestion of biotinylated proteins and  MSE analysis
Streptavidin Sepharose was re-suspended in 200 µL of 
digestion buffer. Twenty microlitres of trypsin were then 
added and incubated overnight at 37° C. The samples 
were centrifuged at 14,100×g for 2 min at room tempera-
ture and the supernatant was collected. Chromatographic 
separation was achieved using Waters UPLC column 
(1.7 µm, 75 µm × 150 mm, 10 K psi). The mobile phase, 
used at a flow rate of 0.3 µL/min, with a gradient of a mix-
ture of (A) 0.1% formic acid in water and (B) 0.1% formic 
acid in acetonitrile programmed as follows: initial 97% A 
for 1 min, reduced to 60% A in 60 min, then decreased to 
5% in 2 min, held for 15 min, again increased to 97% A in 
3 min. The column temperature was set at 28 °C.
Mass spectrometry analysis was performed utiliz-
ing a Waters Xevo quadrupole time of flight (Q-TOF) 
micro™ mass spectrometer coupled directly to Waters 
nanoACQUITY UPLC system (Waters Corp). Peptides 
were separated with a UPLC BEH C18 Column (1.7 µm, 
75 µm × 150 mm, 10 K psi). The mobile phase, used at a 
flow rate of 0.3 µL/min, with a gradient of a mixture of 
(A) 0.1% formic acid in water and (B) 0.1% formic acid 
in acetonitrile was programmed as follows: initial 97% A 
for 1 min, decreased to 60% A in 60 min, then decreased 
to 5% for 2 min, held at this for 15 min, again increased 
to 97% A in 3  min. The column temperature was set at 
28 °C.
All analysis was performed using positive mode elec-
trospray ionization (ESI). The LC–MS spectrometer was 
operated in the  MSE data independent acquisition mode. 
LC–MS data was collected in an alternating low energy 
MS and elevated energy MS/MS  (MSE) mode of acquisi-
tion. In low energy MS mode the data were collected at a 
constant collision energy of 6 eV. In elevated energy MS/
MS mode the collision energy was ramped from 15 to 
40 eV on laboratory frame energy to collect product ions 
of all precursors identified from the MS scan. Samples 
were injected into the mass spectrometer in triplicates.
Data analysis
The LC MS and LC MS/MS data were processed using 
ProteinLynx Global Server (PLGS) version 2.5 (Waters 
Corporation). The quantification of protein levels was 
achieved by the addition of an internal protein stand-
ard (alcohol dehydrogenase trypsin digest) to which the 
data set was normalized. The protein identification was 
based on MS/MS peak lists which were generated by  MSE 
data independent collision induced fragmentation using 
a Rattus database. Protein identifications were accepted 
with greater than three fragment ions per peptide, seven 
fragment ions per protein and one unique peptide per 
protein identified. Carbamidomethyl cysteine was set as 
a fixed modification while oxidized methionine was set as 
a variable modification. Trypsin was set as a proteolytic 
enzyme, and up to two missed cleavages were allowed. 
Peptide tolerance set at 10 ppm with fragment ion toler-
ance of 0.5 amu. When a peptide was not detected in the 
MSE experiment a nominal amount of 0.01 was reported 
to avoid zeros in subsequent calculations. The p values of 
the expression ratios of irradiated and control rats were 
determined using two tailed student’s t test.
Results
To determine the effect of irradiation on AVF endothe-
lium, and to study the up-regulated membrane proteins 
in response to irradiation, 18 mass spectrometry runs 
were analysed from 3 irradiated rats and 3 control rats. 
Triplicate samples were run for each rat. The proteom-
ics data detected a total of 74 proteins in the irradiated 
rats, 20 of them were annotated as membrane proteins. A 
total of 104 proteins were detected in control rats, 37 of 
them were annotated as membrane proteins.
Twelve membrane proteins shared their presence in 
both irradiated and control rats (Table 1). Their average 
concentrations (fmol) and average ratios of expression 
(irradiated: control) were calculated to determine the 
changes in membrane protein level following irradiation.
The expression of Alpha-1 inhibitor protein increased 
in irradiated rats by (2.3) fold, however this increase 
wasn’t significant (p = 0.164), while annexin-A2 and 
lumican showed significant decrease (p = 0.025 and 0.041 
respectively).
Interestingly, eight membrane proteins were detected 
in irradiated rats only, and not in control rats, due to 
their extremely low concentrations in the control rats 
(Table 2), such as profilin-1, ESAM-1, potassium voltage 
gated channel protein and chloride intracellular channel 
protein-2, they have shown significant up-regulation (293 
fold, 28 fold, 390 fold and 60 fold respectively).
A list of all membrane proteins that were present in 
irradiated rats are presented in (Table 3), while the mem-
brane proteins that were present in the control rats are 
presented in (Table 4). 
Non membrane protein expression also differed 
between irradiated and control rats. Actin, myosin and 
tubulin were highly expressed in irradiated rats, while 
vimentin and fibroblast growth factor-16 expression were 
detected in control rats only (Additional file 1: Tables S1 
and S2, Additional file 2: Table S4).
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Discussion
This study aimed to identify differentially expressed 
surface proteins in the animal model of AVM subjected 
to irradiation, as these proteins could have utility for 
molecular targeting. In general the total number of pro-
teins detected by mass spectrometry analysis in the con-
trol rats was higher than irradiated rats. This is expected 
since irradiation at doses 15–20 Gy may cause some cell 
death while doses higher than 100 Gy causes cell hyper-
trophy [12].
The eight membrane proteins that were present mainly 
in irradiated rats, such as profilin-1, ESAM-1, potassium 
voltage gated channel and chloride intracellular channel 
protein 2, are of importance to this study due to their sig-
nificant up-regulation (293 fold, 28 fold, 390 fold and 60 
fold respectively), as well as the non-membrane proteins 
highly expression in irradiated rats, such as actin, myosin 
and tubulin.
Profilin-1 is an actin binding protein; hence its 
increased expression is expected due to increase expres-
sion of actin in irradiated rats. Prifilin-1 belongs to the 
profilin family, at high concentrations; it increases the 
ADP-to-ATP exchange on G-actin, and prevents the 
polymerization of actin, whereas at low concentrations 
it enhances it [13, 14]. Profilin-1 contribution to actin 
dynamics at plasma membrane is part of many other 
activities. Profilin-1 has been regarded as a tumour-
suppressor molecule for breast cancer and the up-regu-
lation of prifilin-1 after irradiation, induced apoptosis in 
pancreatic cancer cells [14, 15]. A ligand for profilin-1 
have been identified,  p42pop which is a novel Myb-tran-
scription factor [16]. Due to its association with plasma 
membrane actins, profilin-1 may well be regarded as a 
potential candidate for the AVM ligand directed vascular 
therapy to deliver thrombotic agents.
Potassium voltage gated channel protein is 
another membrane protein that was up-regulated 
Table 1 Membrane proteins shared between  irradiated (R) and  control (C) rats, their sequence accession number, 
molecular weight, average concentration on column (fmol) and average concentration ratios (irradiated: control); n = 18
p < 0.05 indicate statistical significance
Protein name Accession # MW Ave (fmol) in R SD Ave (fmol) in C SD Fold change 
(R:C)
(p)
Alpha 1 macroglobulin Q63041 168,494.1 4.2 1.67 5.8 0.29 0.8 0.222
Biglycan P47853 42,105.52 1.5 0.1 3.0 0.26 0.5 0.32
Annexin A1 P07150 39,171.71 1.4 0.83 2.1 0.13 0.7 0.288
Annexin A2 Q07936 38,963.45 5.0 0.07 6.0 0.60 0.8 0.025
Lumican P51886 38,678.25 2.6 0.30 4.1 0.18 0.6 0.041
GTPase Q8K3L6 37,665.02 5.2 0.2 18.9 0.1 0.3
Prolargin Q9EQP5 43,521.63 3.5 0.62 3.9 2.28 0.9 0.727
Serine protease inhibitor P05544 46,448.34 1.1 0.01 8.1 0.01 0.1 0.82
Alpha 1 inhibitor 3 P14046 165,142.2 6.2 0.32 2.7 0.05 2.3 0.164
Collagen alpha 1 P02454 138,980.1 7.4 0.40 7.3 0.05 1.0 0.618
Collagen alpha 2 P02466 130,077.4 2.1 0.20 7.8 0.21 0.3 0.07
Decorin Q01129 40,147.32 1.8 1.15 3.1 0.06 0.6 0.205
Table 2 Membrane proteins present in  irradiated rats (R) only, their accession number, molecular weight average 
concentration on column (fmol), and average concentration ratios (irradiated: control); n = 9
p < 0.05 indicate statistical significance
Protein name Accession # MW Ave (fmol) R SD Ave fmol C Fold R:C (p)
Profilin 1 P62963 15,128.34 2.9 3.27 0.01 293.625 0.001
Endothelial cell specific molecule-1 P97682 21,101.27 0.6 0.39 0.01 28.98 0.002
Bone morphogenetic protein 3 P49002 53,416.56 7.9 4.95 0.01 790 0.001
Potassium voltage gated channel subfamily 
A member 5
P19024 67,237.32 3.4 2.42 0.01 340 0.005
Myelin protein P06907 27,741.78 7.4 6.48 0.01 737.5 0.017
Chloride intracellular channel protein 2 Q5M883 28,446.33 0.6 0.39 0.01 60 0.051
Vomeromodulin Q63751 10,890.35 7.2 5.07 0.01 720 0.090
Prothyroliberin P01150 29,454.97 5.3 3.70 0.01 530 0.022
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significantly in irradiated rats. This protein is an ion 
channel transport protein and membrane potential that 
facilitates the flow of potassium ions down an electro-
chemical gradient (Zhang et  al. 2003). In the brain the 
greatest density occurs in the cerebral cortex. Previous 
studies have shown increased expression of this protein 
in response to irradiation [17, 18]. Potassium channels 
are commonly expressed in tumour cells and have been 
Table 3 Membrane proteins identified by LC–MS/MS in irradiated rats, their accession number and classifications
Protein name Uniprot accession # Membrane 
protein 
classification
Profilin-1 P62962 Cytoskeleton
Annexin A2 P07356 Extracellular matrix
Decorin Q01129 =
Lumican P51886 =
Biglycan P47853 =
Annexin A1 P10107 =
Collagen alpha 1 P02454 =
Prolargin Q9EQP5 =
Collagen alpha 2 P08123 =
Alpha 1 macroglobulin P06238 =
Prothyroliberin P01150 =
GTPase P20171 Lipid anchor
Alpha 1 inhibitor 3 P04585 =
Mylein P02688 Peripheral
Potassium voltage gated channel P15387 Multi pass
Serine protease inhibitor P27958 Single pass type 1
Endothelial cell specific molecule 1 P35918 =
Chloride intracellular channel protein 2 O35433 Multi pass
Vomeromodulin Q63751 Extracellular matrix
Bone morphogenetic protein 3 Q06826 =
Table 4 Membrane proteins identified my LCMS/MS in control rats, their accession number and classifications
Protein name Uniprot accession # Membrane 
protein 
classification
Protein name Uniprot accession # Membrane 
protein 
classification
Annexin A2 P07356 Extracellular matrix GTPase P20171 Lipid anchor
Annexin A1 P10107 = Serine protease inhibitor P27958 Single pass type 1
Collagen alpha 1 P02454 = Alpha 1 inhibitor3 P10824 Peripheral
Lumican P51886 = Annexin 5 P14668 Extracellular matrix
Collagen alpha 2 P08123 = Vesicle associated memb.
prot.3
P63035 Single pass type IV
Neuromodulin Q63751 = Fibroblast growth factor 16 P13109 Extracellular matrix
Decorin Q01129 = Prolargin Q9EQP5 =
Regulating synaptic mem-
brane exocytosis protein
Q9JIR4 Peripheral Biglycan P47853 =
Ig gamma 2A chain P01865 Single pass Alpha 1 macroglobulin P06238 =
ATP synthase subunit alpha P10719 Peripheral Alpha actinin 4 P57780 =
Serotransferrin P12346 Basement Jouberin Q6DTM3 =
Heat shock 75 P48721 Extracellular Beta defensin 15 Q322H6 =
PKHD domain containing 
transmembrane protein C1
Q6T3A5 Transmembrane Plasma kallikrein P14272 =
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a target for many drugs. Different agents have been used 
to target potassium channels in animal tumour models 
and in clinical trials; they have also been used for the 
treatment of other diseases such as type 2 diabetes and 
hypertension, with minimal side effects [19–21].The 
interference with potassium channels offered a new ther-
apeutic characteristic for cancer treatment because this 
channel is sometimes favourably expressed in tumour 
cells and sometimes the abnormally expressed form is 
different from the physiological one, this made it easy to 
block the potential side effects of the drug by channel tar-
geting in ordinary tissues [18, 22]. Our future work will 
focus on studying the differential expression of potassium 
voltage gated channels in AVM vessels and normal ves-
sels. The fact that this protein is extracellularly accessible 
may simplify targeting and drug design. This protein will 
be investigated as a potential target for ligand directed 
therapy for brain AVMs.
Chloride intracellular channel protein 2 is another volt-
age gated ion channel transmembrane protein that was 
up-regulated significantly in irradiated rats. Chloride 
channel proteins have also been used as molecular tar-
gets for cancer therapy [23]. Previous studies on human 
lung cancer cells and laryngeal cancer cells have shown 
increased expression of chloride intracellular channel 
proteins 4 and 1 in response to irradiation, suggesting 
these proteins as important and novel targets for anti 
cancer therapy and radiotherapy for cancer cells [24, 25]. 
Therefore our future work will also include extensive 
study of chloride intracellular channel protein 2 as poten-
tial target for molecular therapy for brain AVM.
Endothelial cell specific molecule-1 (ESM-1) is yet 
another up-regulated membrane protein expressed sig-
nificantly in the irradiated rats. ESM-1 is endothelial cell 
adhesion molecule that is also expressed on platelets. In 
2009, Stalker et al., showed that after platelet activation, 
ESM-1 was localized to the junctions between adjacent 
platelets, suggesting a role for this protein in thrombus 
formation [26]. Exposed tissue factor that was found in 
some irradiated blood vessels lacking the endothelial lin-
ing suggested one mechanism in which thrombosis may 
occur post radiosurgery, however no significant differ-
ences in expression have been shown after irradiation [7, 
8]. Further investigation of the ESM-1 role in thrombosis 
of AVM vessels may provide potential molecular target 
for the AVM vascular therapy.
A number of non-membrane proteins also showed 
increased expression in the irradiated rats, such as 
actin, myosin and tubulin. This data is in agreement 
with our in  vitro proteomics study of the murine cer-
ebral endothelial cells in response to irradiation [11]. The 
expression of these cytoplasmic proteins may well be the 
result of radiation-stimulated surface expression, as we 
have used Sulfo-NHS-LC-biotin in this study, which is 
known to inhibit cell membrane penetration [27]. Previ-
ous in  vitro studies of endothelial cells have shown cell 
surface translocation of intracellular proteins in response 
to irradiation [11, 28, 29]. Additionally, this data also in 
accordance with previous data obtained from human 
cerebral endothelial cultures where it was suggested that 
radiosurgery by Gamma knife induces transformation of 
fibroblasts into contractile elements (i.e. actin and myo-
sin) in AVM vessels similar to myofibroblasts, which may 
contribute to the obliteration of AVMs after radiosur-
gery [30, 31]. Furthermore, in 2009 a study by Sekis et al., 
showed that irradiation did not up-regulate the vascu-
lar endothelial growth factor in masctocytoma cell lines 
[32]. Interestingly in this study, fibroblast growth factor 
was detected mainly in control rats AVF tissues; this may 
support the transformation of fibroblast into contractile 
elements in the irradiated rats. The expression patterns 
of these proteins are intriguing; they could potentially 
be targeted with the use of ligands to deliver thrombotic 
agents to AVM vessels.
Our previous proteomics investigation of the murine 
endothelial cerebral cell cultures (bEnd3) revealed a large 
number of membrane proteins that were differentially 
expressed between irradiated and non-irradiated cells 
[11], many of those proteins are identified in this study 
as well ((Additional file 1: Table S3)), this consistency is 
important in candidate selection for AVM molecular 
therapy. The proteins identified from our in  vitro and 
in  vivo proteomics studies, are currently being investi-
gated as potential targets for the ligand-directed molec-
ular targeting trials in the rat model of AVM. Future 
studies will further include irradiation-induced changes 
in human primary endothelial cell cultures from resected 
AVM tissues. The significance of this novel research lies 
in its potential for rapid translation into therapies for 
currently untreatable brain AVMs, and for patients who 
currently have to wait up to 3  years after undergoing 
radiosurgery, for their AVM to be occluded completely, 
while they remain at risk of haemorrhage.
Additional files
Additional file 1: Table S1. Expression of actins, tubulin, myosin, fibro-
blast growth factor-16 and vimentin in control rats. Table S2. Expression 
of actins, tubulin and myosin in irradiated rats. Table S3. Membrane 
proteins present in murine endothelial cell cultures, and the rats model 
of AVM.
Additional file 2: Table S4. MSE raw data for one control rat, as an 
exemplification.
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